DCA Latest Hope For Cancer Cure

sizcache = "0" sizset = "54">

Every year brings hope for new cancer drugs to the media forefront, and this year began with praskom.Tvar that was previously used in metabolic disorders has been tested in cultured human cancer cell lines in Petri dishes and mice with cancer and had very promising results.

in the previous paragraph is probably told every year for the past 30 years. First of all, do not expect your doctor to be prescribing this product anytime soon, an experiment with mice is only the beginning of the tests. Anyone who suggests that it will help soon is irresponsible or phony.

Unfortunately, the terminally ill cancer patients do not have the time and will be getting their hopes in vain, it happens every year when the cancer research program makes major news.

substance is DCA or dichloroacetate and it has been tested in cultured cancer cells and mice just released in January 2007 in a respectable journal and respected laboratory in Alberta, Canada headed by Evangelos D. Michelakis.

So why all the fuss? It was years away from helping people even in the best case? Yes, probably, but it does raise some ethical debates and issues of hope.

DCA already been tested in people who suffer from other illnesses (adults and children), so you already know that it is reasonably safe drug to the point. This can potentially save you years of clinical studies and safety hurdles than if DCA is a brand new drug. So very optimistically within one to two years will begin limited clinical studies in humans.

This is a very optimistic, because money is a problem with this drogom.Droga is so cheap to manufacture that drug companies will not make money from it (it can not be patented too, which makes it more difficult for pharmaceutical companies to make money) and has the potential to reduce current consumption expensive chemotherapies if successful. In other words, drug companies will not be funding research to find it on the market, and most of you can probably guess that it takes BA-zillion dollars to fund research. This opens up an ethical debate for pharmaceutical companies to the public, that is, they will hinder the development of useful drugs, if it does not help, and even interfere with their bottom line?

laboratory that produced the results of doing something a little out of the ordinary so far to raise money, they actually seek direct help from the public funds. You can actually make a donation here

This drug also raises other ethical issues. Why not give cancer patients diagnosed a few months of life? There are potentially thousands of patients who have undergone chemotherapy and reached the stage where chemotherapy is no longer useful and that was taken off to die weeks later. There would be no shortage of people willing to sign a waiver to take DCA today.

How can a doctor tell a patient terminally ill with cancer a few weeks or months that they will not prescribe DCA, because it is potentially unsafe or does not have proper administrative approval or has not been shown to ultimately help in enough formal studies?

Well, most doctors will tell you that, but they will tell their hospital or governing Medical Association will not let them. These faceless administrations can hide and delay the request for DCA until they die of old age, let alone cancer, and nobody will be blamed.

is essentially tell their patients to stop the fight against cancer and just accept their death soon, sorry, it's a cold way to put it, but it is difficult to put a good spin on it. It's not that doctors do not worry, it's just accepted the way things are done for decades.

Unfortunately, the current terminal ill cancer patients taken off chemotherapy so that they can die in a few months will have to rely on themselves, relatives and carers at this time.

This is now forcing many non-health professionals to seek DCA on their own. Nobody wants to see trains civilians over cancer therapy duties, but it will happen with this drug as it can be taken orally in a glass of water and is cheap if you get your hands on it. You can buy it at the corner store, but I foresee a great demand to find a way to get out there and some phony, fake DCA will even sell them without a doubt.

Who would have thought of small molecules may have raised the debate on health care business, political, health authority and ethical treatment of terminally ill people.